Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,995 | -23,754 | -14,969 | -10,514 | -4,601 |
| Depreciation Amortization | N/A | 258 | 257 | 230 | N/A |
| Income taxes - deferred | N/A | N/A | 7 | 6 | N/A |
| Accounts payable and accrued liabilities | -240 | 8,366 | 377 | -303 | 3,585 |
| Other Working Capital | 335 | 6,065 | 465 | -300 | -139 |
| Other Operating Activity | 2,497 | -1,924 | 4,616 | 4,029 | -2,648 |
| Operating Cash Flow | $-5,403 | $-10,989 | $-9,247 | $-6,852 | $-3,803 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | 12,158 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $12,158 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -589 | -473 | -353 | -352 | N/A |
| Common Stock Issued | N/A | 6,007 | 6,007 | 6,007 | N/A |
| Other Financing Activity | 5,328 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $4,739 | $5,534 | $5,654 | $5,655 | $N/A |
| Beginning Cash Position | 12,750 | 6,047 | 5,962 | 5,962 | 5,962 |
| End Cash Position | 12,086 | 12,750 | 2,369 | 4,765 | 2,159 |
| Net Cash Flow | $-664 | $6,703 | $-3,593 | $-1,197 | $-3,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,403 | -10,989 | -9,247 | -6,852 | -3,803 |
| Free Cash Flow | -5,403 | -10,989 | -9,247 | -6,852 | -3,803 |